bicalutamide and entinostat

bicalutamide has been researched along with entinostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1
Björkman, M; Halonen, P; Iljin, K; Kaivanto, E; Kallioniemi, OP; Nees, M; Sara, H	1

Other Studies

2 other study(ies) available for bicalutamide and entinostat

Article	Year
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013
Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. International journal of cancer, 2008, Dec-15, Volume: 123, Issue:12 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Nitriles; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prostatic Neoplasms; Protein Synthesis Inhibitors; Pyridines; Receptors, Androgen; Tosyl Compounds; Up-Regulation	2008

Article

Year

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013

Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.

International journal of cancer, 2008, Dec-15, Volume: 123, Issue:12

Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Nitriles; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prostatic Neoplasms; Protein Synthesis Inhibitors; Pyridines; Receptors, Androgen; Tosyl Compounds; Up-Regulation

2008